Caplyta Dosage
Generic name: LUMATEPERONE 42mg
Dosage form: capsule
Drug class: Atypical antipsychotics
Medically reviewed by Drugs.com. Last updated on Jun 29, 2023.
Recommended Dosage
The recommended dosage of CAPLYTA is 42 mg administered orally once daily with or without food. Dose titration is not required.
Dosage Recommendations for Concomitant Use with Moderate or Strong CYP3A4 Inhibitors
Coadministration with Strong CYP3A4 Inhibitors
The recommended dosage for patients receiving strong CYP3A4 inhibitors is CAPLYTA 10.5 mg once daily [see Drug Interactions (7.1)].
Coadministration with Moderate CYP3A4 Inhibitors
The recommended dosage for patients receiving moderate CYP3A4 inhibitors is CAPLYTA 21 mg once daily [see Drug Interactions (7.1)].
Dosage Recommendations for Patients with Hepatic Impairment
For patients with moderate or severe hepatic impairment (Child-Pugh class B or C), the recommended dosage of CAPLYTA is 21 mg once daily [see Use in Specific Populations (8.6)].
Frequently asked questions
More about Caplyta (lumateperone)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (158)
- Drug images
- Side effects
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: atypical antipsychotics
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
